SCHEDULE 13G/A: Nantahala Capital Management Discloses 9.99% Stake in InspireMD, Inc.

Nantahala Capital Management, LLC, along with its managing members Wilmot B. Harkey and Daniel Mack, has reported a beneficial ownership of 9.99% in InspireMD, Inc.'s common stock as of March 31, 2025.

Summary

• Nantahala Capital Management, LLC, Wilmot B. Harkey, and Daniel Mack collectively reported beneficial ownership of 3,037,935 shares of InspireMD, Inc. common stock.
• This ownership represents 9.99% of the total outstanding shares of InspireMD, Inc.
• The reported shares include 719,918 shares that can be acquired by the Reporting Persons within sixty days through the exercise of warrants.
• Nantahala Capital Management, LLC is classified as an investment adviser, while Wilmot B. Harkey and Daniel Mack are control persons.
• The shares are held by funds and separately managed accounts under Nantahala's control, with shared voting and dispositive power over all 3,037,935 shares.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of InspireMD, Inc.

Sentiment

Score: 6

Explanation: The sentiment is slightly positive as it indicates significant institutional interest and confidence in the company, although the filing itself is purely factual and does not contain performance data.

Positives

• The disclosure of a significant stake by an institutional investment firm like Nantahala Capital Management may signal institutional confidence in InspireMD, Inc.'s future prospects.
• The holding of 9.99% indicates a substantial, long-term interest from a sophisticated investor.

Risks

• While the filing certifies that the shares were not acquired for the purpose of changing or influencing control, a large institutional stake could still lead to increased scrutiny or expectations regarding corporate strategy.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding InspireMD, Inc.'s future financial performance or strategic outlook. It solely reports beneficial ownership.

Industry Context

This filing reflects an institutional investor's position in a company operating in the medical device or biotechnology sector. Such disclosures are common and provide transparency into significant ownership stakes, which can influence market perception and investor sentiment within the industry.

Stakeholder Impact

• Shareholders: The disclosure of a significant institutional stake may positively influence investor confidence and potentially the stock's valuation, as it signals a vote of confidence from a sophisticated investor.

Key Dates

Keywords

InspireMD, Nantahala Capital Management, SEC filing, Schedule 13G, beneficial ownership, common stock, institutional investment, equity stake, medical devices, biotechnology